Natac successfully acquires INOREAL to expand their saffron natural product portfolio 21/06/2022 Healthcare Access to innovation International Communication Corporate Natac is dedicated to investigate, develop and sustainably manufacture plant extracts and compounds of natural origin... Partners - Natac Group
DR Healtchare lanza la campaña “Me Again” para dar a conocer el déficit de DAO 9 junio, 20... 16/06/2022 Healthcare Rare diseases DR Healthcare se prepara para el lanzamiento de su nueva campaña de comunicación sobre el déficit de DAO Partners - DR Healthcare
Life Length obtains European authorization for its innovative prostate cancer diagnostic ... 09/06/2022 PROSTAV® tiene por objeto mejorar sustancialmente el diagnóstico de cáncer de próstata; el más frecuente en los hombres... Partners
ORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Small... 08/06/2022 Healthcare Access to innovation Corporate Now has orphan drug designation for SCLC and AML Partners - Oryzon Genomics
Vesismin creates pioneering programme with comprehensive approach to hospital infections 07/06/2022 Healthcare Vesismin offers hospitals and health centres Vesismin Services, the first comprehensive programme to provide a global... Partners - Parc Científic de Barcelona
Why Not Next Generation Sequencing? 02/06/2022 Healthcare 16 June 2022, 13:00-14:00 CET Next generation sequencing has forever changed how we study life, health and disease. Just... Partners - Illumina
BCN HEALTH publishes a study evaluating the hospital incidence and medical costs of chroni... 30/05/2022 Healthcare Corporate BCN HEALTH has published the study ‘Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis... Partners - BCN Health
Report | Clinical trials, impacting people’s lives 20/05/2022 Healthcare To celebrate International Clinical Trials Day, we want to highlight the importance of research and how relevant it is... AseBio
#NewMember | "AseBio will enable us to provide differential and disruptive value" 19/05/2022 Healthcare Innovative drugs Meet Mikrobiomik, our new member. We talk with Juan Basterra, CEO of the company AseBio - Mikrobiomik
Peaches Biotech publishes positive “in vivo” results of its drug PRS CK STORM 18/05/2022 Healthcare Innovative drugs Personalized medicine Advanced therapies The results show the high efficacy and safety of PRS CK STORM as a medicine to prevent and treat the cytokine storm... Partners - PEACHES BIOTECH S.L.
